Macro Finance
Summit Therapeutics Jumps on $2 Billion AstraZeneca Investment
Bloomberg Markets·September 28, 2026·1 min read
Summit Therapeutics Inc. shares jumped after AstraZeneca Plc announced a $2 billion strategic equity investment in the cancer drugmaker. The two companies will jointly develop drugs. The investment signals a major partnership in oncology, boosting Summit's market position. Financial terms and specific drug candidates were not disclosed in the announcement.
Read at Bloomberg MarketsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.